Christoffer Clemmensen

9.4k total citations · 4 hit papers
88 papers, 5.2k citations indexed

About

Christoffer Clemmensen is a scholar working on Physiology, Endocrine and Autonomic Systems and Molecular Biology. According to data from OpenAlex, Christoffer Clemmensen has authored 88 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Physiology, 33 papers in Endocrine and Autonomic Systems and 28 papers in Molecular Biology. Recurrent topics in Christoffer Clemmensen's work include Regulation of Appetite and Obesity (32 papers), Adipose Tissue and Metabolism (22 papers) and Diabetes Treatment and Management (19 papers). Christoffer Clemmensen is often cited by papers focused on Regulation of Appetite and Obesity (32 papers), Adipose Tissue and Metabolism (22 papers) and Diabetes Treatment and Management (19 papers). Christoffer Clemmensen collaborates with scholars based in Denmark, Germany and United States. Christoffer Clemmensen's co-authors include Timo D. Müller, Brian Finan, Richard D. DiMarchi, Matthias H. Tschöp, Randy J. Seeley, Anders B. Klein, M. Tschöp, Karen K. Ryan, Gitte M. Knudsen and Stephen C. Woods and has published in prestigious journals such as Nature, Cell and Nature Communications.

In The Last Decade

Christoffer Clemmensen

85 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FXR is a molecular target for the effects of vertical sleeve gastrectomy

2014 735 citations Christoffer Clemmensen et al. profile →
Animal models of obesity and diabetes mellitus

2018 618 citations Maximilian Kleinert, Christoffer Clemmensen et al. profile →
Blood BDNF concentrations reflect brain-tissue BDNF levels across species

2010 572 citations Anders B. Klein, Rebecca Williamson et al. The International Journal of Neuropsychopharmacology profile →
The New Biology and Pharmacology of Glucagon

2017 297 citations Timo D. Müller, Brian Finan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christoffer Clemmensen Denmark	32	1.9k	1.6k	1.5k	1.2k	798	88	5.2k
Timo D. Müller Germany	44	2.3k 1.2×	2.2k 1.3×	2.4k 1.6×	1.4k 1.2×	1.4k 1.8×	144	6.8k
Olga D. Carlson United States	37	2.5k 1.3×	1.3k 0.8×	1.6k 1.1×	1.1k 1.0×	1.3k 1.7×	64	5.9k
Robin L. Davisson United States	52	1.9k 1.0×	2.6k 1.6×	1.3k 0.8×	779 0.7×	923 1.2×	117	8.1k
André Kleinridders Germany	34	2.2k 1.1×	2.2k 1.3×	816 0.5×	689 0.6×	992 1.2×	57	5.6k
Andrea Fabbri Italy	48	1.4k 0.7×	1.4k 0.9×	3.8k 2.5×	838 0.7×	836 1.0×	155	7.8k
Judith Körner United States	36	2.3k 1.2×	803 0.5×	1.1k 0.7×	2.2k 1.9×	1.1k 1.4×	100	5.3k
David G. Parkes Australia	43	1.3k 0.7×	1.7k 1.0×	2.7k 1.8×	1.6k 1.4×	1.5k 1.9×	112	6.0k
Kozo Hashimoto Japan	41	1.1k 0.6×	1.1k 0.6×	2.0k 1.3×	730 0.6×	718 0.9×	292	7.0k
Stephanie W. Watts United States	42	2.2k 1.1×	1.9k 1.2×	564 0.4×	713 0.6×	312 0.4×	225	5.8k
Joseph Tam Israel	34	983 0.5×	1.2k 0.7×	1.1k 0.8×	957 0.8×	363 0.5×	104	4.8k

Countries citing papers authored by Christoffer Clemmensen

Since Specialization

Citations

This map shows the geographic impact of Christoffer Clemmensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoffer Clemmensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoffer Clemmensen more than expected).

Fields of papers citing papers by Christoffer Clemmensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoffer Clemmensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoffer Clemmensen. The network helps show where Christoffer Clemmensen may publish in the future.

Co-authorship network of co-authors of Christoffer Clemmensen

This figure shows the co-authorship network connecting the top 25 collaborators of Christoffer Clemmensen. A scholar is included among the top collaborators of Christoffer Clemmensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoffer Clemmensen. Christoffer Clemmensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clemmensen, Christoffer, et al.. (2025). Pharmacological but Not Physiological Levels of GDF15 and FGF21 Regulate Body Weight and Glycemic Control in Obese Mice. The FASEB Journal. 39(15). e70918–e70918.

Clemmensen, Christoffer, et al.. (2025). A hypothalamus–brainstem circuit governs the prioritization of safety over essential needs. Nature Neuroscience. 28(7). 1473–1485. 2 indexed citations

Lund, Jens, et al.. (2025). Food insecurity promotes adiposity in mice. Obesity. 33(6). 1087–1100. 1 indexed citations

Ranea‐Robles, Pablo, et al.. (2025). Time-Resolved Effects of Short-term Overfeeding on Energy Balance in Mice. Diabetes. 74(4). 502–513. 2 indexed citations

Lund, Jens, et al.. (2024). Lead-in calorie restriction enhances the weight-lowering efficacy of incretin hormone-based pharmacotherapies in mice. Molecular Metabolism. 89. 102027–102027. 5 indexed citations

Magkos, Faidon, Thorkild I. A. Sørensen, David Raubenheimer, et al.. (2024). On the pathogenesis of obesity: causal models and missing pieces of the puzzle. Nature Metabolism. 6(10). 1856–1865. 26 indexed citations

Fritzen, Andreas M., Jacob Lercke Skytte, Jens Lund, et al.. (2024). Atlas of exercise-induced brain activation in mice. Molecular Metabolism. 82. 101907–101907. 10 indexed citations

Ranea‐Robles, Pablo, Sarah Falk, Dylan M. Rausch, et al.. (2024). Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R. Nature Communications. 15(1). 1192–1192. 8 indexed citations

Klein, Anders B., Pablo Ranea‐Robles, Trine S. Nicolaisen, et al.. (2023). Cross-species comparison of pregnancy-induced GDF15. American Journal of Physiology-Endocrinology and Metabolism. 325(4). E303–E309. 11 indexed citations

10.

Roostalu, Urmas, Casper G. Salinas, Jacob Lercke Skytte, et al.. (2023). Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging. Neuropharmacology. 238. 109637–109637. 16 indexed citations

11.

Rial‐Pensado, Eva, Laurence Canaple, Romain Guyot, et al.. (2023). Neuronal Blockade of Thyroid Hormone Signaling Increases Sensitivity to Diet-Induced Obesity in Adult Male Mice. Endocrinology. 164(4). 6 indexed citations

12.

Nielsen, John E., Birgitte Grønkær Toft, Lars R. Ingerslev, et al.. (2022). RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma. British Journal of Cancer. 127(3). 408–421. 6 indexed citations

13.

Husted, Anna Sofie, Louise J. Skov, Thomas Morville, et al.. (2022). Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2. Endocrinology. 163(6). 23 indexed citations

14.

Lund, Jens, Christoffer Clemmensen, & Thue W. Schwartz. (2022). Outrunning obesity with Lac-Phe?. Cell Metabolism. 34(8). 1085–1087. 13 indexed citations

15.

González-Franquesa, Alba, Ben Stocks, Melissa L. Borg, et al.. (2021). Discovery of thymosin β4 as a human exerkine and growth factor. American Journal of Physiology-Cell Physiology. 321(5). C770–C778. 18 indexed citations

16.

Ratner, Cecilia, Zhenyan He, Kaare V. Grunddal, et al.. (2019). Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent Pathway. Diabetes. 68(6). 1329–1340. 35 indexed citations

17.

Lundsgaard, Anne‐Marie, Andreas M. Fritzen, Trine S. Nicolaisen, et al.. (2019). Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation. Journal of Lipid Research. 61(1). 10–19. 23 indexed citations

18.

Pfuhlmann, Katrin, Sonja C. Schriever, Peter Baumann, et al.. (2018). Celastrol-Induced Weight Loss Is Driven by Hypophagia and Independent From UCP1. Diabetes. 67(11). 2456–2465. 37 indexed citations

19.

Smajilovic, Sanela, Christoffer Clemmensen, Lars Dan Johansen, et al.. (2012). The l-α-amino acid receptor GPRC6A is expressed in the islets of Langerhans but is not involved in l-arginine-induced insulin release. Amino Acids. 44(2). 383–390. 50 indexed citations

20.

Klein, Anders B., Rebecca Williamson, Martin A. Santini, et al.. (2010). Blood BDNF concentrations reflect brain-tissue BDNF levels across species. The International Journal of Neuropsychopharmacology. 14(3). 347–353. 572 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact